Modernizing FDA regulations to advance a value-driven health care system
By Michelle Drozd | June 8, 2017
A modern regulatory framework is the foundation of an innovative health care system that allows stakeholders to work together to deliver better outcomes for patients. To advance critical...
Read More
ICYMI: Avalere and FasterCures develop new value framework from patient perspective
By Holly Campbell | May 31, 2017
In case you missed it, a year-long collaboration between Avalere and FasterCures has resulted in the first value framework from the patient perspective. Unlike other frameworks which include...
Read More
Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist
By Robert Zirkelbach | May 31, 2017
Meet Laurel and Ian. Laurel is a patient living with multiple sclerosis (MS), and Ian is a scientist developing new treatments to help Laurel and the other 2.3 million people with MS live longer,...
Read More
A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements
By Robert Zirkelbach | May 15, 2017
Today, we released the latest chapter of GOBOLDLY™ advertising titled New World, featuring the extraordinary breakthroughs in science being discovered by biopharmaceutical researchers.
Read More
ICYMI: The New Era of Medicine initiative spotlights genomics in NYC
By Andrew Powaleny | April 28, 2017
As the understanding of each person’s unique DNA makeup continues to grow (better known as genomics), personalized medicine is rapidly reaching new heights.
Read More
A new era in genomics
By Andrew Powaleny | April 26, 2017
Personalized medicine has taken on a new meaning with the mapping of the human genome.
Read More
Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs
By Robert Zirkelbach | April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...
Read More
Mental health in the New Era of Medicine
By Bill Chin, M.D. | April 18, 2017
Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...
Read More
This is not a special effect: New video shows the destruction of a rogue cell
By Robert Zirkelbach | April 10, 2017
In the latest video of our Cells series, part of the GOBOLDLY™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million...
Read More
Exploring the new era of medicine
By Bill Chin, M.D. | February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...
Read More
Medicare Monday (100)
340B Spotlight (36)
Cost & Consequence (0)
